National Cancer Institute
Cancer Imaging Program
Print Friendly Version | Text Only | Contact Us  
Home
About CIP
Research Funding
Programs & Resources
 
Specialized Initiatives
 
Information Systems
 
Ultrasound Research Interface
 
Bioinformatics & Bioengineering
 
Funded Research
 
NIH Roadmap
Clinical Trials
Reports & Publications
News & Meetings
Imaging Information
Imaging Guidelines
Programs & Resources
Development of Clinical Imaging Drugs & Enhancers (DCIDE)
Introduction
Opportunity
Program
Scope
Process
Requests for Support
Evaluation Criteria
Intellectual Property & Industrial Intervention
Assessment & Oversight
Metrics for Judging Success
Additional Sources of Information
FAQs
Approved DCIDE Projects

DCIDE is no longer taking applications, as of August 2009. Imaging drug development resources should be requested through the new NExT/CBC program which has its own application and review process. See NCI Experimental Therapeutics Program (NExT) There are 4 review dates per year, instead of the previous DCIDE submission and review process.

See Funded DCIDE Projects

Contact regarding programmatic issues:
Barbara Y. Croft, Ph.D.
Cancer Imaging Program, NCI
6130 Executive Blvd., Suite 6000
Bethesda, MD 20892
Telephone: 301-496-9531
Fax: 301-480-3507
E-mail: bc129b@nih.gov

Next Section >  Main

National Cancer InstituteDepartment of Health & Human ServicesNational Institutes of HealthFirstGov.gov